bioSyntagma

bioSyntagma

Biotechnology Research 275 N. Gateway Drive 2 employees
Employees
2
Contacts
1
Emails
1
Phones
1

bioSyntagma Overview

Headquarters
275 N. Gateway Drive
Website
biosyntagma.com
Industry
Biotechnology Research
Employees
2
Founded
2015
Funding
196.0K
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About bioSyntagma

bioSyntagma is a precision medicine company dedicated to transforming how cancer is treated by providing deep data on the uniqueness of each person’s cancer. The company’s Molecular Fingerprint™ (mPrint™) platform creates a comprehensive, multi-omic and spatial profile of tissue to get a complete and informed understanding of the patient’s cancer so they can be matched with relevant therapies and recommended course of actions that prevent acquired drug resistance. bioSyntagma’s mPrint™ platform serves the needs of clinicians, academic researchers, and drug developers to advance the implementation of precision medicine for cancer treatment.

bioSyntagma Contact Details

People in AeroLeads
1
With contact data
1
Email contacts
1
100.0% coverage
Phone contacts
1
100.0% coverage

bioSyntagma Org Chart

Sample employees and titles
Name Title Contact
Colleen Ziegler Co-founder at Biosyntagma
Email Phone

Department Contact Coverage

Department Contacts Email Phone
General 1 1 1

Compare Similar Companies to bioSyntagma